Top

Abdominal Radiology

Published in:

Open Access 08-11-2023 | Nephrostomy | Kidneys, Ureters, Bladder, Retroperitoneum

Application of ultrasound-guided percutaneous nephrostomy in the treatment of a solitary kidney with hydronephrosis due to renal tuberculosis

Authors: Bingsong Zhang, Lei Li, Gengchen Zhang, Jinshan Wang, Bingsheng Cao, Zhuo Li

Published in: Abdominal Radiology | Issue 2/2024

Abstract

Purpose

To investigate the value of ultrasound-guided percutaneous nephrostomy and nephrostomy tube replacement for treating a solitary kidney with hydronephrosis due to renal tuberculosis.

Methods

Clinical data of patients with a solitary kidney with hydronephrosis caused by renal tuberculosis who underwent ultrasound-guided percutaneous nephrostomy in our hospital from January 2011 to December 2022 were retrospectively analyzed. The associated success rate and complications were statistically analyzed, pre- and post-catheterization changes in serum creatinine and blood urea nitrogen levels were compared, success rate and complications of nephrostomy tube replacement in patients with long-term catheterization were statistically analyzed, and the impact of long-term catheterization on patient life was investigated.

Results

Overall, 32 patients aged 17–75 years (average age: 44.1 ± 16.9 years) underwent ultrasound-guided percutaneous nephrostomy. Sixty-three punctures were performed; the puncture success rate was 100%. The levels of serum creatinine and blood urea nitrogen of patients decreased after catheterization, and the differences between the pre-catheterization and post-catheterization were significant (P < 0.05). There were 1, 3, and 12 cases of serious, minor, and fistula-related complications, respectively. The mean duration of the indwelling catheter was 56.7 ± 36.2 (range, 13–120) months. The number of nephrostomy tube replacements was 344 times, and the success rate was 100%. All patients could take care of the puncture point by themselves.

Conclusion

Ultrasound-guided percutaneous nephrostomy and nephrostomy tube replacement have a high success rate and few complications, which can improve the renal function of patients. It is of great value for treating a solitary kidney with hydronephrosis caused by renal tuberculosis.

Figueiredo AA, Lucon AM, Srougi M. Urogenital Tuberculosis. Microbiol Spectr. 2017;5(1). https://doi.org/10.1128/microbiolspec.TNMI7-0015-2016. PMID: 28087922.

Al-Shehari W A, Yin Y A, Wang X, Wang Y, Sun H, Fu Y, Zhang F. Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018. Epidemiol Infect. 2022 150: e146. https://doi.org/10.1017/S0950268822001261. PMID: 35856270.

Liu P, Wang Y, Hao S, Qin Y. Comparison of the CapitalBio™Mycobacterium RT-PCR detection test and Xpert MTB/RIF assay for diagnosis of renal tuberculosis. Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):559-563. https://doi.org/10.1007/s10096-020-04052-x. PMID: 32990820.CrossRefPubMed

Chandran S, Rahman A, Norris JM, Tiberi S, Kunst H. Diagnostic pitfalls of urogenital tuberculosis. Tropical medicine & international health: TM & IH. 2021;26(7):753-9. https://doi.org/10.1111/tmi.13583. PMID: 33817915.CrossRef

Krishnamoorthy S, Gopalakrishnan G. Surgical management of renal tuberculosis. Indian J Urol. 2008 Jul;24(3):369-75. https://doi.org/10.4103/0970-1591.42620. PMID: 19468471.CrossRefPubMedPubMedCentral

Pabon-Ramos W M, Dariushnia S R, Walker T G, d'Othée B J, Ganguli S, Midia M, Siddiqi N, Kalva S P, Nikolic B. Quality Improvement Guidelines for Percutaneous Nephrostomy. J Vasc Interv Radiol. 2016 Mar;27(3):410-4. https://doi.org/10.1016/j.jvir.2015.11.045. PMID: 26803576CrossRefPubMed

Carrafiello G, Laganà D, Mangini M, Lumia D, Recaldini C, Bacuzzi A, Marconi A, Mira A, Cuffari S, Fugazzola C. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review. Radiol Med. 2006 Jun;111(4):562-71. https://doi.org/10.1007/s11547-006-0051-2. PMID: 16779542CrossRefPubMed

Gow J G. Genito-urinary tuberculosis. A study of the disease in one unit over a period of 24 years. Ann R Coll Surg Engl. 1971 49(1):50-70. PMID: 4997559.

Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-598. https://doi.org/10.1038/s41585-019-0228-9. PMID: 31548730.CrossRefPubMed

10.

Pai M, O'Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects Semin Respir Crit Care Med. 2008 Oct;29(5):560-8. https://doi.org/10.1055/s-0028-1085707. PMID: 18810689.CrossRefPubMed

11.

Krishnamoorthy S, Palaniyandi V, Kumaresan N, Govindaraju S, Rajasekaran J, Murugappan I, Venkat R, Muthulatha N. Aspects of Evolving Genito Urinary Tuberculosis-A Profile of Genito Urinary Tuberculosis (GUTB) in 110 Patients. J Clin Diagn Res. 2017 11(9): PC01-PC05. https://doi.org/10.7860/JCDR/2017/25882.10557. PMID: 29207771.

12.

Kim E J, Lee W, Jeong W Y, Choi H, Jung I Y, Ahn J Y, Jeong S J, Ku N S, Choi J Y, Choi Y H, Song Y G, Kim J M. Chronic kidney disease with genitourinary tuberculosis: old disease but ongoing complication. BMC Nephrol. 2018 Aug 2;19(1):193. https://doi.org/10.1186/s12882-018-0994-2. PMID: 30071831.CrossRefPubMedPubMedCentral

13.

Lee J Y, Park H Y, Park S Y, Lee S W, Moon H S, Kim Y T, Lee T Y, Park H Y. Clinical Characteristics of Genitourinary Tuberculosis during a Recent 10-Year Period in One Center. Korean J Urol. 2011 Mar;52(3):200-5. https://doi.org/10.4111/kju.2011.52.3.200. PMID: 21461285.CrossRefPubMedPubMedCentral

14.

Wagaskar V G, Chirmade R A, Baheti V H, Tanwar H V, Patwardhan S K, Gopalakrishnan G. Urinary Tuberculosis with Renal Failure: Challenges in Management. J Clin Diagn Res. 2016 10(1):PC01-3. https://doi.org/10.7860/JCDR/2016/16409.7017. PMID: 26894119.

15.

Degirmenci T, Gunlusoy B, Kozacioglu Z, Arslan M, Ceylan Y, Ors B, Minareci S. Utilization of a modified Clavien Classification System in reporting complications after ultrasound-guided percutaneous nephrostomy tube placement: comparison to standard Society of Interventional Radiology practice guidelines. Urology, 2013, 81(6): 1161-1167. https://doi.org/10.1016/j.urology.2013.02.038. PMID: 23618426.CrossRefPubMed

16.

Yoo MJ, Bridwell RE, Inman BL, Henderson JD, Long B. Approach to nephrostomy tubes in the emergency department. Am J Emerg Med. 2021 Dec; 50: 592-596. https://doi.org/10.1016/j.ajem.2021.09.034. PMID: 34592566.CrossRefPubMed

17.

Efesoy O, Saylam B, Bozlu M, Çayan S, Akbay E. The results of ultrasound-guided percutaneous nephrostomy tube placement for obstructive uropathy: A single-centre 10-year experience. T Turk J Urol. 2018 Jul;44(4):329-334. https://doi.org/10.5152/tud.2018.25205. PMID: 29799408.CrossRef

18.

Montvilas P, Solvig J, Johansen T E. Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates. Eur J Radiol. 2011 Nov;80(2):553-8. https://doi.org/10.1016/j.ejrad.2011.01.109. PMID: 21353753.CrossRefPubMed

19.

Chalmers N, Jones K, Drinkwater K, Uberoi R, Tawn J. The UK nephrostomy audit. Can a voluntary registry produce robust performance data? Clin Radiol. 2008 63(8):888-94. https://doi.org/10.1016/j.crad.2007.10.021. PMID: 18625353.

20.

Millward S F. Percutaneous nephrostomy: a practical approach. asc Interv Radiol. 2000 Sep;11(8):955-64. https://doi.org/10.1016/s1051-0443(07)61322-0. PMID: 10997456.

Title: Application of ultrasound-guided percutaneous nephrostomy in the treatment of a solitary kidney with hydronephrosis due to renal tuberculosis
Authors: Bingsong Zhang
Lei Li
Gengchen Zhang
Jinshan Wang
Bingsheng Cao
Zhuo Li
Publication date: 08-11-2023
Publisher: Springer US
Keywords: Nephrostomy
Nephrostomy
Tuberculosis
Tuberculosis
Ultrasound
Ultrasound
Published in: Abdominal Radiology / Issue 2/2024
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-023-04068-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2024

Validity of an automated screening Dixon technique for quantifying hepatic steatosis in living liver donors

Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis

Cryoablation in the liver: how accurately does the iceball predict the ablation zone?

Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores

Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanisms

Feasibility and safety of bipolar radiofrequency track cautery during percutaneous image-guided abdominal biopsy procedures

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials